Replies to post #61217 on $heff's $tation of $tocks & $olid DD

[smittygoodcall]

I agree Sheff...I really think the FDA and the company have designed this study to give them the best chance for positive results. I think since the drug is very safe, the FDA wants this as bad as ACAD does.

[$hylo]

ACAD..…$heff, glad you’re back in. Seems like ACAD's run up is about to start. Your impeccable timing is just amazing. ACAD will definitely be a very strong catalyst mover, with less than 20 trading days to go before the much anticipated and expected positive top line results. Looking for a $3.50-$4.00 run up pre-results and $4.50-$5.00 upon positive data release come end of Nov.

Thanks again for your incredible foresight. IMO, you are spot on when you said 2 months ago that "ACAD is the best catalyst value play in Q4 of 2012".
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=79337445

[$heff]

ACAD..$2.55 Strong opening this morning getting to $2.62 after earnings & guidance call yesterday.